BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38225880)

  • 1. Locally Advanced Gastric Cancer Management: A Cost-Effectiveness Analysis.
    Prasath V; Quinn PL; Arjani S; Li S; Oliver JB; Mahmoud O; Jaloudi M; Hajifathalian K; Chokshi RJ
    Am Surg; 2024 Jun; 90(6):1268-1278. PubMed ID: 38225880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decision analysis comparing three strategies for peritoneal lavage cytology testing in staging of gastric cancer in China.
    He Q; Zhu J; Wang A; Ji K; Ji X; Zhang J; Wu X; Li X; Bu Z; Ji J
    Cancer Med; 2020 Dec; 9(23):8940-8949. PubMed ID: 33047873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate Cancer in the United States.
    Yee CW; Harvey MJ; Xin Y; Kirson NY
    Pharmacoeconomics; 2024 Feb; 42(2):231-247. PubMed ID: 37934376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States.
    Jethwa PR; Patel TD; Hajart AF; Eloy JA; Couldwell WT; Liu JK
    World Neurosurg; 2016 Mar; 87():65-76. PubMed ID: 26548828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
    Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
    Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication.
    Kowada A
    Dig Dis Sci; 2021 Dec; 66(12):4220-4226. PubMed ID: 33417196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Paclitaxel + Ramucirumab Combination Therapy for Advanced Gastric Cancer Progressing After First-line Chemotherapy in Japan.
    Saito S; Muneoka Y; Ishikawa T; Akazawa K
    Clin Ther; 2017 Dec; 39(12):2380-2388. PubMed ID: 29175097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.
    Chongqing T; Liubao P; Xiaohui Z; Jianhe L; Xiaomin W; Gannong C; Siying W; Lihui O; Ziying Z
    Pharmacoeconomics; 2014 Mar; 32(3):235-43. PubMed ID: 23709451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of palliative emergent surgery versus endoscopic stenting for acute malignant colonic obstruction.
    Quinn PL; Arjani S; Ahlawat SK; Chokshi RJ
    Surg Endosc; 2021 May; 35(5):2240-2247. PubMed ID: 32430522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of endovascular vs surgical arteriovenous fistula creation in the United States.
    Mulaney-Topkar B; Ho VT; Sgroi MD; Garcia-Toca M; George EL
    J Vasc Surg; 2024 Feb; 79(2):366-381.e1. PubMed ID: 37952783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of robotic versus laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a prospective trial-based economic evaluation.
    Lu J; Wu D; Huang JB; Lin J; Xu BB; Xue Z; Zheng HL; Lin GS; Shen LL; Li P; Wang JB; Lin JX; Chen QY; Cao LL; Xie JW; Zheng CH; Huang CM
    Surg Endosc; 2023 Oct; 37(10):7472-7485. PubMed ID: 37395806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma: cost-effectiveness analysis.
    Gosselin-Tardif A; Abou-Khalil M; Mata J; Guigui A; Cools-Lartigue J; Ferri L; Lee L; Mueller C
    BJS Open; 2020 Oct; 4(5):830-839. PubMed ID: 32762036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective.
    Marupuru S; Arku D; Axon DR; Villa-Zapata L; Yaghoubi M; Slack MK; Warholak T
    Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):831-841. PubMed ID: 37243493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of 3D image-guided brachytherapy compared with 2D brachytherapy in the treatment of locally advanced cervical cancer.
    Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
    Brachytherapy; 2015; 14(1):29-36. PubMed ID: 25443528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.
    Sherman SK; Lange JJ; Dahdaleh FS; Rajeev R; Gamblin TC; Polite BN; Turaga KK
    JAMA Oncol; 2019 Feb; 5(2):236-242. PubMed ID: 30489611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness Analysis of Nonoperative Management Versus Early Drilling for Stable Osteochondritis Dissecans Lesions of the Knee in Skeletally Immature Patients.
    LeBrun DG; DeFrancesco CJ; Fabricant PD; Lawrence JTR
    Arthroscopy; 2021 Feb; 37(2):624-634.e2. PubMed ID: 33271176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinence.
    Bernstein MA; Purdy CH; Becker A; Magar R
    Clin Ther; 2014 Jun; 36(6):890-905.e3. PubMed ID: 24815061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan computed tomography versus selective computed tomography in stable, young adults after blunt trauma with moderate mechanism: a cost-utility analysis.
    Lee WS; Parks NA; Garcia A; Palmer BJ; Liu TH; Victorino GP
    J Trauma Acute Care Surg; 2014 Oct; 77(4):527-33; discussion 533. PubMed ID: 25250590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis: Lymph Node Transfer vs Lymphovenous Bypass for Breast Cancer-Related Lymphedema.
    Sekigami Y; Char S; Mullen C; Huber K; Cao Y; Buchsbaum R; Graham R; Nardello S; Singhal D; Chatterjee A
    J Am Coll Surg; 2021 Jun; 232(6):837-845. PubMed ID: 33684564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.